BioXcel Therapeutics, Inc. (BTAI)
1.51
-0.09
(-5.62%)
USD |
NASDAQ |
Mar 20, 16:00
1.53
+0.02
(+1.32%)
After-Hours: 20:00
BioXcel Therapeutics Shareholders Equity (Quarterly) : -88.92M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 391.48M |
| Puma Biotechnology, Inc. | 130.34M |
| Quince Therapeutics, Inc. | 1.059M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 44.79M |
| Total Liabilities (Quarterly) | 133.71M |
| Debt to Equity Ratio | -1.229 |
| Current Ratio | 1.175 |
| Net Debt Paydown Yield | -2.21% |